EUVIMEDEUVIMED entdecken
Systematische Übersicht

Maintaining Testosterone Therapy Throughout Ovarian Stimulation for Trans Masculine Individuals: A Systematic Review

Gabriela Leon, Dalia Karol, Brenna Leslie, Jennia Michaeli iD

LGBT Health · 01.04.2026 · 13 (3) · 139-147

DOI: 10.1177/23258292261437289 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift LGBT Health, online erschienen am 02.04.2026. Verfasst von Gabriela Leon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Testosterone, Ovulation Induction, Transgender Persons. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This systematic review aimed to summarize evidence on continuous testosterone therapy during ovarian stimulation in trans masculine individuals.

Methods

A search of Medline, EMBASE, Cochrane, PubMed, CINAHL, Web of Science, and ClinicalTrials.gov was conducted through October 2024 in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies reporting ovarian stimulation on continuous testosterone therapy were included. The Joanna Briggs Institute Checklist for Case Reports was used to assess risk of bias, and descriptive statistics and qualitative synthesis were conducted.

Results

The review included six articles involving eight patients. Median age at oocyte cryopreservation was 27 years (range 20–34), and median age at initiation of testosterone was 24 (range 18–27). An antagonist protocol was used for seven patients. Letrozole was given to three patients during their cycle. Oocytes were cryopreserved for four patients, embryos were cryopreserved at the time of stimulation for two patients, and two patients created embryos from cryopreserved oocytes. The median number of oocytes retrieved from seven patients was 20 (range 13–56), and the median number of oocytes cryopreserved from six patients was 22.5 (range 9–30). To date, three embryo transfers (two frozen and one fresh) have been reported, all resulting in live births.

Conclusion

Live births, oocyte and embryo cryopreservation, are possible across a range of stimulation protocols under testosterone exposure. As trans masculine patients report gender dysphoria with the fertility preservation process, these case reports present an opportunity for reconsideration of current practices and propose a paradigm shift in fertility care for transgender individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TestosteroneOvulation InductionTransgender PersonsHumansFemaleMaleCryopreservationAdult

Stichwörter der Autor:innen

fertility preservationovarian stimulationtestosteronetransgender

Substanzen

Testosterone

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario, Canada.
  • Sidney Liswood Library, Sinai Health, Toronto, Ontario, Canada.
  • Mount Sinai Fertility, Sinai Health, Toronto, Ontario, Canada.

ORCID-Profile: Jennia Michaeli

Zitieren

APA

Leon, G., Karol, D., Leslie, B., & Michaeli, J. (2026). Maintaining Testosterone Therapy Throughout Ovarian Stimulation for Trans Masculine Individuals: A Systematic Review. LGBT Health, 13(3), 139-147. https://doi.org/10.1177/23258292261437289

Vancouver

Leon G, Karol D, Leslie B, Michaeli J. Maintaining Testosterone Therapy Throughout Ovarian Stimulation for Trans Masculine Individuals: A Systematic Review. LGBT Health. 2026;13(3):139-147. doi:10.1177/23258292261437289

BibTeX
@article{Leon2026,
  author = {Leon, Gabriela and Karol, Dalia and Leslie, Brenna and Michaeli, Jennia},
  title = {Maintaining Testosterone Therapy Throughout Ovarian Stimulation for Trans Masculine Individuals: A Systematic Review},
  journal = {LGBT Health},
  year = {2026},
  volume = {13},
  number = {3},
  pages = {139--147},
  doi = {10.1177/23258292261437289}
}
Kostenlos starten →